Gen-003-002 HSV2 Clinical Study

[shocked80]

I recently emailed Quest to join a clinical study for HSV2. Ive a attached a porrion of the email for everyone to read.

 

below is the text of the message that was sent out last week to our HSV-2

email list, communicating the preliminary results from the GEN-003-002

study.

 

Best,

 

Laura

 

 

"Dear Quest HSV email list,

 

We wanted to take a moment to share with you the initial results from the

GEN-003-002 trial, which were released on Wednesday.

 

Genocea was very excited to announce a >50% reduction in viral shedding

after the 3rd and last dose of vaccine at the optimal dose level. Five out

of six 6 dosing groups showed significant reduction in viral shedding. All

dose groups also showed significant reduction on clinical outbreaks.

Reduction in viral shedding has the potential to reduce both physical

discomfort to those living with genital herpes, and the risk of transmission

to HSV-negative partners.

 

These results could not have been achieved without the hard work and

dedication of our study subjects, to whom we are profoundly grateful.

 

While the study is still in progress and more data forthcoming, this is a

very exciting starting point.

 

We look forward to sharing more information with you as it becomes

available.

 

See Genocea's press release here:

http://ir.genocea.com/releasedetail.cfm?releaseid=914052

 

Best,

 

Dr Jay & the team at Quest

 

[Danaaaaaasaur]

Awesome! Thanks for sharing :)